ABOM

Short answer: usually no — compounded GLP‑1s are generally a last-resort option because they carry safety, quality and legal risks. Before you consider compounding, try other, safer and often less risky routes. What to try first Appeal the denial. Ask your prescriber to submit a prior authorization or a letter of medical necessity (peer-to‑peer review can help). Many denials are reversed on appeal. Contact the manufacturer. Novo Nordisk offers Wegovy patient support and savings programs that can reduce out‑of‑pocket cost for commercially insured patients and has patient assistance resources for qualifying people. Check other FDA‑approved weight‑loss drugs your insurer may cover: Saxenda (liraglutide), Qsymia (phentermine/topiramate), Contrave (bupropion/naltrexone), or Zepbound (tirzepatide) — coverage varies, but one of these may be covered where Wegovy was not. If you have type 2 diabetes, discuss GLP‑1s or tirzepatide prescribed for diabetes (Ozempic, Mounjaro) — insurers more often cover them for diabetes, and they also cause weight loss (but use and dosing should be guided by your clinician). Look into manufacturer savings/coupon sites and discount services to lower cash price: Novo Nordisk patient support for Wegovy, and tools such as GoodRx or Blink Health can sometimes reduce out‑of‑pocket cost (coupons aren’t valid for all payers and not for Medicare/Medicaid). If you consider other care routes See an obesity medicine specialist (ABOM‑certified) or endocrinologist — they can help with appeals, alternative prescriptions, or programmatic weight‑management options (medical clinics, academic centers, bariatric surgery evaluation if appropriate). Consider clinical trials for weight‑loss medications at academic centers if eligible. About compounded GLP‑1s — what you need to know Compounded GLP‑1 peptides (semaglutide/tirzepatide made by compounding pharmacies) are not FDA‑approved products. That means no standard FDA oversight of manufacturing, potency, sterility, and purity. Known risks: inconsistent dose/potency, contamination/sterility failures (risk of infection), unknown source of active peptide, no guaranteed cold‑chain or stability data, and limited post‑market safety reporting. Some states or pharmacy boards restrict compounding of certain biological peptides; large insurers and many health systems will not accept prescriptions for compounded biologics. If you still consider a compounded product (only after exhausting safer options), only use a reputable sterile compounding pharmacy that: Provides certificates of analysis and sterility testing, Is accredited (ask about USP <797>/USP <800> compliance and membership/affiliation with PCCA or similar), Will disclose source of active ingredients and compounding protocols, Has clear counseling on storage, handling and returns, And get explicit informed-consent documentation from your prescriber about risks. Where to look for help (specific names) Novo Nordisk Wegovy patient support/savings — contact the manufacturer for assistance and eligibility for savings or patient assistance. GoodRx or Blink Health — price comparison and coupons for cash pay options (verify which payers they work with). ABOM Directory (American Board of Obesity Medicine) — to find an obesity medicine specialist near you who can help with appeals and alternative care. Local academic weight‑management or bariatric centers — for multidisciplinary care and access to clinical trials. If you consider compounding, ask your clinician for referrals to a reputable compounding pharmacy and verify USP/PCCA/board credentials. Bottom line Compounded GLP‑1s are not the best general option because of safety and quality concerns. First pursue an appeal, manufacturer assistance, covered alternative medications, or specialist care. If after careful consideration and informed consent you still consider a compounded product, only use a highly reputable sterile compounding pharmacy and discuss risks with your prescriber. If you want, tell me: (1) whether you have diabetes or other medical issues, (2) whether you have commercial insurance vs Medicare/Medicaid, and (3) whether you want help drafting an appeal letter or locating a nearby ABOM specialist — I can help with the next step.

Mentioned in position 8 of 9